{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:50Z","timestamp":1791828590177,"version":"4.3.4"},"reference-count":38,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"name":"AIG \u2013 Italian Glycogenosis Association NPO","award":["0009477"],"award-info":[{"award-number":["0009477"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Glycogen Storage Disease type III (GSD III) is a metabolic disorder resulting\nfrom a deficiency of the Glycogen Debranching Enzyme (GDE), a large monomeric protein\n(approximately 170 kDa) with cytoplasmic localization and two distinct enzymatic activities:\n4-\u03b1-glucantransferase and amylo-\u03b1-1,6-glucosidase. Mutations in the Agl gene, with consequent\ndeficiency in GDE, lead to the accumulation of abnormal\/toxic glycogen with shorter chains (phosphorylase\nlimit dextrin, PLD) in skeletal and\/or heart muscle and\/or in the liver. Currently, there is\nno targeted therapy, and available treatments are symptomatic, relying on specific diets.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Enzyme Replacement Therapy (ERT) might represent a potential therapeutic strategy\nfor GSD III. Moreover, the single-gene nature of GSD III, the subcellular localization of GDE,\nand the type of affected tissues represent ideal conditions for exploring gene therapy approaches.\nToward this direction, we designed a synthetic, codon-optimized cDNA encoding the human\nGDE.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>This gene yielded high amounts of soluble, enzymatically active protein in Escherichia\ncoli. Moreover, when transfected in Human Embryonic Kidney cells (HEK-293), it successfully\nencoded a functional GDE.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These results suggest that our gene or protein might complement the missing function\nin GSD III patients, opening the door to further exploration of therapeutic approaches for this\ndisease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298665307430240628063339","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T07:01:33Z","timestamp":1721286093000},"page":"519-531","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Functional Human Glycogen Debranching Enzyme Encoded by a Synthetic Gene: Its Implications for Glycogen Storage Disease Type III Management"],"prefix":"10.2174","volume":"31","author":[{"given":"Doriana","family":"Triggiani","sequence":"first","affiliation":[{"name":"Department of Sustainability, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic\nDevelopment, Casaccia Research Center, Via Anguillarese 301, 00123, Rome, Italy"},{"name":"AIG, Associazione Italiana\nGlicogenosi, ONLUS, Via Roma, 2\/G 20090 Assago, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia C.","family":"Demurtas","sequence":"additional","affiliation":[{"name":"Department of Sustainability, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic\nDevelopment, Casaccia Research Center, Via Anguillarese 301, 00123, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Illiano","sequence":"additional","affiliation":[{"name":"Department of Sustainability, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic\nDevelopment, Casaccia Research Center, Via Anguillarese 301, 00123, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Massa","sequence":"additional","affiliation":[{"name":"Department of Sustainability, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic\nDevelopment, Casaccia Research Center, Via Anguillarese 301, 00123, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pasquo","sequence":"additional","affiliation":[{"name":"Department of FSNTECFIS-DIM ENEA, Italian National\nAgency for New Technologies, Energy and Sustainable Economic Development, Frascati Research Center, Via\nEnrico Fermi 45, 00044, Frascati RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dionisi-Vici","sequence":"additional","affiliation":[{"name":"Division of Metabolic Diseases and Hepatology, Ospedale Pediatrico\nBambino Ges\u00f9 IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Marino","sequence":"additional","affiliation":[{"name":"Department of Sustainability, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic\nDevelopment, Casaccia Research Center, Via Anguillarese 301, 00123, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Department of Sustainability, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic\nDevelopment, Casaccia Research Center, Via Anguillarese 301, 00123, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Franconi","sequence":"additional","affiliation":[{"name":"Department of Sustainability, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic\nDevelopment, Casaccia Research Center, Via Anguillarese 301, 00123, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/TRD-160006","volume":"1","author":"Chen M.A.","year":"2016","unstructured":"Chen M.A.; Weinstein D.A.; Glycogen storage diseases: Diagnosis, treatment and outcome. Transl Sci Rare Dis  2016,1(1),45-72","journal-title":"Transl Sci Rare Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.21037\/atm.2018.10.59","volume":"6","author":"Kanungo S.","year":"2018","unstructured":"Kanungo S.; Wells K.; Tribett T.; El-Gharbawy A.; Glycogen metabolism and glycogen storage disorders. Ann Transl Med  2018,6(24),474","journal-title":"Ann Transl Med"},{"key":"ref=3","author":"Stone W.L.","year":"2023","unstructured":"Stone W.L.; Basit H.; Adil A.;  StatPearls  2023","journal-title":"StatPearls"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1042\/BJ20111416","volume":"441","author":"Roach P.J.","year":"2012","unstructured":"Roach P.J.; Depaoli-Roach A.A.; Hurley T.D.; Tagliabracci V.S.; Glycogen and its metabolism: Some new developments and old themes. Biochem J  2012,441(3),763-787","journal-title":"Biochem J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5114\/aoms.2019.83063","volume":"17","author":"Szyma\u0144ska E.","year":"2021","unstructured":"Szyma\u0144ska E.; J\u00f3\u017awiak-Dzi\u0119cielewska D.A.; Gronek J.; Niewczas M.; Czarny W.; Rokicki D.; Gronek P.; Hepatic glycogen storage diseases: Pathogenesis, clinical symptoms and therapeutic management. Arch Med Sci  2021,17(2),304-313","journal-title":"Arch Med Sci"},{"key":"ref=6","author":"Schreuder A.B.","year":"2010","unstructured":"Schreuder A.B.; Rossi A.; Gr\u00fcnert S.C.; Derks T.G.J.;  GeneReviews  2010","journal-title":"GeneReviews"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","volume":"12","author":"Kishnani P.S.","year":"2010","unstructured":"Kishnani P.S.; Austin S.L.; Arn P.; Bali D.S.; Boney A.; Case L.E.; Chung W.K.; Desai D.M.; El-Gharbawy A.; Haller R.; Smit G.P.A.; Smith A.D.; Hobson-Webb L.D.; Wechsler S.B.; Weinstein D.A.; Watson M.S.; Glycogen Storage Disease Type III diagnosis and management guidelines. Genet Med  2010,12(7),446-463","journal-title":"Genet Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","volume":"39","author":"Sentner C.P.","year":"2016","unstructured":"Sentner C.P.; Hoogeveen I.J.; Weinstein D.A.; Santer R.; Murphy E.; McKiernan P.J.; Steuerwald U.; Beauchamp N.J.; Taybert J.; Lafor\u00eat P.; Petit F.M.; Hubert A.; Labrune P.; Smit G.P.A.; Derks T.G.J.; Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome. J Inherit Metab Dis  2016,39(5),697-704","journal-title":"J Inherit Metab Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1432-1033.1975.tb03911.x","volume":"51","author":"Taylor C.","year":"1975","unstructured":"Taylor C.; Cox A.J.; Kernohan J.C.; Cohen P.; Debranching enzyme from rabbit skeletal muscle. Purification, properties and physiological role. Eur J Biochem  1975,51(1),105-115","journal-title":"Eur J Biochem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1038\/ncomms11229","volume":"7","author":"Zhai L.","year":"2016","unstructured":"Zhai L.; Feng L.; Xia L.; Yin H.; Xiang S.; Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations. Nat Commun  2016,7(1),11229","journal-title":"Nat Commun"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-5793(75)80254-7","volume":"58","author":"Bates E.J.","year":"1975","unstructured":"Bates E.J.; Heaton G.M.; Taylor C.; Kernohan J.C.; Cohen P.; Debranching enzyme from rabbit skeletal muscle; Evidence for the location of two active centres on a single polypeptide chain. FEBS Lett  1975,58(1-2),181-185","journal-title":"FEBS Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12862-014-0183-2","volume":"14","author":"Zmasek C.M.","year":"2014","unstructured":"Zmasek C.M.; Godzik A.; Phylogenomic analysis of glycogen branching and debranching enzymatic duo. BMC Evol Biol  2014,14(1),183","journal-title":"BMC Evol Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1128\/JB.01442-13","volume":"196","author":"Nguyen D.H.D.","year":"2014","unstructured":"Nguyen D.H.D.; Park J.T.; Shim J.H.; Tran P.L.; Oktavina E.F.; Nguyen T.L.H.; Lee S.J.; Park C.S.; Li D.; Park S.H.; Stapleton D.; Lee J.S.; Park K.H.; Reaction kinetics of substrate transglycosylation catalyzed by TreX of Sulfolobus solfataricus and effects on glycogen breakdown. J Bacteriol  2014,196(11),1941-1949","journal-title":"J Bacteriol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0888-7543(92)90003-B","volume":"13","author":"Yang-Feng T.L.","year":"1992","unstructured":"Yang-Feng T.L.; Zheng K.; Yu J.; Yang B.Z.; Chen Y.T.; Kao F.T.; Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics  1992,13(4),931-934","journal-title":"Genomics"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/geno.1996.0611","volume":"38","author":"Bao Y.","year":"1996","unstructured":"Bao Y.; Dawson T.L.; Chen Y.T.; Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5\u2032 flanking region. Genomics  1996,38(2),155-165","journal-title":"Genomics"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0378-1119(97)00291-6","volume":"197","author":"Bao Y.","year":"1997","unstructured":"Bao Y.; Yang B.Z.; Dawson T.L.; Chen Y.T.; Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: Identification of multiple tissue-specific isoforms. Gene  1997,197(1-2),389-398","journal-title":"Gene"},{"key":"ref=17","first-page":"72","volume":"26","author":"Lucchiari S.","year":"2007","unstructured":"Lucchiari S.; Santoro D.; Pagliarani S.; Comi G.P.; Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency. Acta Myol  2007,26(1),72-74","journal-title":"Acta Myol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/GIM.0b013e3181d94eaa","volume":"12","author":"Goldstein J.L.","year":"2010","unstructured":"Goldstein J.L.; Austin S.L.; Boyette K.; Kanaly A.; Veerapandiyan A.; Rehder C.; Kishnani P.S.; Bali D.S.; Molecular analysis of the AGL gene: Identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III. Genet Med  2010,12(7),424-430","journal-title":"Genet Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10038-006-0045-x","volume":"51","author":"Endo Y.","year":"2006","unstructured":"Endo Y.; Horinishi A.; Vorgerd M.; Aoyama Y.; Ebara T.; Murase T.; Odawara M.; Podskarbi T.; Shin Y.S.; Okubo M.; Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. J Hum Genet  2006,51(11),958-963","journal-title":"J Hum Genet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jimd.12355","volume":"44","author":"Berling \u00c9.","year":"2021","unstructured":"Berling \u00c9.; Lafor\u00eat P.; Wahbi K.; Labrune P.; Petit F.; Ronzitti G.; O\u2019Brien A.; Narrative review of glycogen storage disorder type  with a focus on neuromuscular, cardiac and therapeutic aspects. J Inherit Metab Dis  2021,44(3),521-533","journal-title":"J Inherit Metab Dis"},{"key":"ref=21","year":"2012","unstructured":"Glycogen Storage Disease Type III.  Available from:  https:\/\/www.ncbi.nlm.nih.gov\/medgen\/6641#:~:text=Glycogen%20storage%20disease%20type%20III%20(also%20known%20as%20GSDIII%20or,especially%20the%20liver%20and%20muscles. (accessed on 22-5-2024)2012"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13023-014-0196-3","volume":"9","author":"Mayorandan S.","year":"2014","unstructured":"Mayorandan S.; Meyer U.; Hartmann H.; Das A.M.; Glycogen storage disease type III: Modified Atkins diet improves myopathy. Orphanet J Rare Dis  2014,9(1),196","journal-title":"Orphanet J Rare Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1016\/j.bbadis.2018.07.031","volume":"1864","author":"Pagliarani S.","year":"2018","unstructured":"Pagliarani S.; Lucchiari S.; Ulzi G.; Ripolone M.; Violano R.; Fortunato F.; Bordoni A.; Corti S.; Moggio M.; Bresolin N.; Comi G.P.; Glucose-free\/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice. Biochim Biophys Acta Mol Basis Dis  2018,1864(10),3407-3417","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/advances\/nmz092","volume":"11","author":"Ross K.M.","year":"2020","unstructured":"Ross K.M.; Ferrecchia I.A.; Dahlberg K.R.; Dambska M.; Ryan P.T.; Weinstein D.A.; Dietary management of the glycogen storage diseases: Evolution of treatment and ongoing controversies. Adv Nutr  2020,11(2),439-446","journal-title":"Adv Nutr"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ymthe.2017.12.019","volume":"26","author":"Vidal P.","year":"2018","unstructured":"Vidal P.; Pagliarani S.; Colella P.; Costa Verdera H.; Jauze L.; Gjorgjieva M.; Puzzo F.; Marmier S.; Collaud F.; Simon Sola M.; Charles S.; Lucchiari S.; van Wittenberghe L.; Vignaud A.; Gjata B.; Richard I.; Laforet P.; Malfatti E.; Mithieux G.; Rajas F.; Comi G.P.; Ronzitti G.; Mingozzi F.; Rescue of GSDIII phenotype with gene transfer requires liver- and muscle-targeted GDE expression. Mol Ther  2018,26(3),890-901","journal-title":"Mol Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.omtm.2020.05.034","volume":"18","author":"Lim J.A.","year":"2020","unstructured":"Lim J.A.; Choi S.J.; Gao F.; Kishnani P.S.; Sun B.; A novel gene therapy approach for GSD III using an aav vector encoding a bacterial glycogen debranching enzyme. Mol Ther Methods Clin Dev  2020,18,240-249","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fpls.2016.00054","volume":"7","author":"Demurtas O.C.","year":"2016","unstructured":"Demurtas O.C.; Massa S.; Illiano E.; De Martinis D.; Chan P.K.S.; Di Bonito P.; Franconi R.; Antigen production in plant to tackle infectious diseases flare up: The case of SARS. Front Plant Sci  2016,7,54","journal-title":"Front Plant Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1432-1033.1967.tb00133.x","volume":"2","author":"Hers H.G.","year":"1967","unstructured":"Hers H.G.; Verhue W.; Hoof F.; The determination of amylo-1,6-glucosidase. Eur J Biochem  1967,2(3),257-264","journal-title":"Eur J Biochem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/0929866526666191014154047","volume":"27","author":"Rodriguez-Hernandez M.","year":"2020","unstructured":"Rodriguez-Hernandez M.; Triggiani D.; Ivison F.; Demurtas O.C.; Illiano E.; Marino C.; Franconi R.; Massa S.; Expression of a functional recombinant human glycogen debranching enzyme (hgde) in N. benthamiana plants and in hairy root cultures. Protein Pept Lett  2020,27(2),145-157","journal-title":"Protein Pept Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e61473","DOI":"10.1371\/journal.pone.0061473","volume":"8","author":"Demurtas O.C.","year":"2013","unstructured":"Demurtas O.C.; Massa S.; Ferrante P.; Venuti A.; Franconi R.; Giuliano G.; A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection. PLoS One  2013,8(4),e61473","journal-title":"PLoS One"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1172\/JCI1722","volume":"101","author":"Kikuchi T.","year":"1998","unstructured":"Kikuchi T.; Yang H.W.; Pennybacker M.; Ichihara N.; Mizutani M.; Van Hove J.L.; Chen Y.T.; Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest  1998,101(4),827-833","journal-title":"J Clin Invest"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13052-018-0562-1","volume":"44","author":"Concolino D.","year":"2018","unstructured":"Concolino D.; Deodato F.; Parini R.; Enzyme replacement therapy: efficacy and limitations. Ital J Pediatr  2018,44(S2)(Suppl. 2),117-126","journal-title":"Ital J Pediatr"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"Van den Hout J.M.P.","year":"2004","unstructured":"Van den Hout J.M.P.; Kamphoven J.H.J.; Winkel L.P.F.; Arts W.F.M.; Klerk J.B.C.D.; Loonen M.C.B.; Vulto A.G.; Cromme-Dijkhuis A.; Weisglas-Kuperus N.; Hop W.; Hirtum H.V.; Diggelen O.P.V.; Boer M.; Kroos M.A.; Doorn P.A.V.; Voort E.V.; Sibbles B.; Corven E.J.J.M.V.; Brakenhoff J.P.J.; Hove J.V.; Smeitink J.A.M.; Jong G.; Reuser A.J.J.; Ploeg A.T.V.; Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics  2004,113(5),e448-e457","journal-title":"Pediatrics"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"Kishnani P.S.","year":"2007","unstructured":"Kishnani P.S.; Corzo D.; Nicolino M.; Byrne B.; Mandel H.; Hwu W.L.; Leslie N.; Levine J.; Spencer C.; McDonald M.; Li J.; Dumontier J.; Halberthal M.; Chien Y.H.; Hopkin R.; Vijayaraghavan S.; Gruskin D.; Bartholomew D.; van der Ploeg A.; Clancy J.P.; Parini R.; Morin G.; Beck M.; De la Gastine G.S.; Jokic M.; Thurberg B.; Richards S.; Bali D.; Davison M.; Worden M.A.; Chen Y.T.; Wraith J.E.; Recombinant human acid \u03b1-glucosidase. Neurology  2007,68(2),99-109","journal-title":"Neurology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/mt.2009.37","volume":"17","author":"Zhu Y.","year":"2009","unstructured":"Zhu Y.; Jiang J.L.; Gumlaw N.K.; Zhang J.; Bercury S.D.; Ziegler R.J.; Lee K.; Kudo M.; Canfield W.M.; Edmunds T.; Jiang C.; Mattaliano R.J.; Cheng S.H.; Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease. Mol Ther  2009,17(6),954-963","journal-title":"Mol Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/nbt1029","volume":"22","author":"Baneyx F.","year":"2004","unstructured":"Baneyx F.; Mujacic M.; Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol  2004,22(11),1399-1408","journal-title":"Nat Biotechnol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1038\/s41598-019-51984-2","volume":"9","author":"Alexaki A.","year":"2019","unstructured":"Alexaki A.; Hettiarachchi G.K.; Athey J.C.; Katneni U.K.; Simhadri V.; Hamasaki-Katagiri N.; Nanavaty P.; Lin B.; Takeda K.; Freedberg D.; Monroe D.; McGill J.R.; Peters R.; Kames J.M.; Holcomb D.D.; Hunt R.C.; Sauna Z.E.; Gelinas A.; Janjic N.; DiCuccio M.; Bar H.; Komar A.A.; Kimchi-Sarfaty C.; Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies. Sci Rep  2019,9(1),15449","journal-title":"Sci Rep"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1371\/journal.pbio.0040180","volume":"4","author":"Kudla G.","year":"2006","unstructured":"Kudla G.; Lipinski L.; Caffin F.; Helwak A.; Zylicz M.; High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol  2006,4(6),e180","journal-title":"PLoS Biol"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665307430240628063339","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231990\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665307430240628063339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:06:56Z","timestamp":1730891216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231990\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665307430240628063339","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}